Skip to main content
NAVB logo

Navidea Biopharmaceuticals, Inc. (NAVB) Stock Analysis

DELISTED 2025

What happened to Navidea Biopharmaceuticals, Inc. (NAVB) stock?

Navidea Biopharmaceuticals, Inc. (NAVB) no longer trades on public markets. It was delisted in December 2025. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Delisting date:
December 2025
Last recorded price (historical):
$0.0001 (last quote on record before the December 2025 delisting; historical, not a current quote)
Vol: 550| 52-wk range: $0.0001 – $0.04
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Navidea Biopharmaceuticals, Inc. (NAVB). Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing precision immunodiagnostic agents and immunotherapeutics. Their Manocept platform targets the CD206 mannose receptor on activated macrophages for diagnostic and therapeutic applications.

Last analyzed: Mar 17, 2026
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing precision immunodiagnostic agents and immunotherapeutics. Their Manocept platform targets the CD206 mannose receptor on activated macrophages for diagnostic and therapeutic applications.
Employees11
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 17, 2026

NAVB trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy NAVB shares?

No. NAVB stopped trading on public markets in December 2025, so the shares are not available through a broker. Anything you see quoted for NAVB elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before NAVB stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Navidea Biopharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.